NIH-funded research Career grant

Understanding how placental signaling affects maternal-fetal diseases

Official title: Mapping inter-cellular trophoblast-decidual signaling to its effects on invasion related maternal-fetal diseases

Funded at University of Connecticut Storrs · NIH-11043061 · Data updated 2026-11-12

This study is looking at how certain cells in the placenta communicate with cells in the uterus to help ensure a healthy pregnancy, and it hopes to find new ways to help moms and babies who might face problems like slow growth or high blood pressure during pregnancy.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Connecticut Storrs
NIH-funded
Lab location1 site (Storrs-Mansfield, United States)
Project startMarch 1, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$73,036
NIH project number3K99HD105973-02S1
Project IDNIH-11043061 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant individuals experiencing complications related to placental invasion, such as fetal growth restriction or preeclampsia.

Less likely to help

Patients without any complications related to placental invasion or those not currently pregnant may not receive benefit from this research.

What this research studies

This research investigates the signaling interactions between trophoblasts and the endometrial stromal fibroblasts, which are crucial for proper placental invasion. By examining these interactions, the study aims to uncover the molecular mechanisms that lead to maternal-fetal diseases, such as fetal growth restriction and preeclampsia. The approach combines computational modeling with experimental validation to create a comprehensive understanding of how these processes work. Patients may benefit from insights that could lead to improved treatments or interventions for conditions related to abnormal placental invasion.

Why it matters

Potential benefit: If successful, this research could lead to better management and treatment options for maternal-fetal diseases, potentially improving outcomes for affected pregnancies.

How similar studies have gone: Previous research has shown promising results in understanding placental biology and its implications for maternal-fetal health, indicating that this approach has potential for success.

Where this research is happening

  • University of Connecticut Storrs
    Storrs-Mansfield, United States
    Active

Researchers

  • Principal investigator: Suhail, Yasir — University of Connecticut Storrs
  • Study coordinator: Suhail, Yasir

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.